(Q34721664)

4 August 2017

title

Combined use of AFP, CEA, CA125 and CAl9-9 improves the sensitivity for the diagnosis of gastric cancer (English)

1 reference

4 August 2017

Chao-Zhu He

1

1 reference

4 August 2017

Kun-He Zhang

2

1 reference

4 August 2017

Qing Li

3

1 reference

4 August 2017

Xiao-Hua Liu

4

1 reference

4 August 2017

Yan Hong

5

1 reference

4 August 2017

Nong-Hua Lv

6

1 reference

4 August 2017

publication date

14 May 2013

1 reference

4 August 2017

1 reference

4 August 2017

volume

13

1 reference

4 August 2017

page(s)

87

1 reference

The use of a combination of Ki-67, Galectin-3, and PTTG can distinguish the benign and malignant thyroid tumor

4 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3655895

Serological assessment of gastric mucosal atrophy in gastric cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3655895

Gastric cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3655895

Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3655895

Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3655895

Tumour marker CA 125 in patients with digestive tract malignancies

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3655895

The use of tumor markers as predictors of prognosis in gastric cancer.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3655895

The prognostic significance of preoperative serum CA 19-9 in patients with resectable gastric carcinoma: comparison with CEA

26 October 2018

1 reference

12 December 2020

Evaluation of seven tumor markers (CA 50, CA 19-9, CA 19-9 TruQuant, CA 72-4, CA 195, carcinoembryonic antigen, and tissue polypeptide antigen) in the pretreatment sera of patients with gastric carcinoma

1 reference

12 December 2020

Correlation between serum CA724 and gastric cancer: multiple analyses based on Chinese population

1 reference

12 December 2020

Investigation of serum tumor markers in the diagnosis of gastric cancer

1 reference

12 December 2020

Predictive value of serum CEA, CA19-9 and CA72.4 in early diagnosis of recurrence after radical resection of gastric cancer

1 reference

12 December 2020

Method comparison for determination of the tumor markers AFP, CEA, PSA and free PSA between Immulite 2000 XPI and Dimension Vista 1500

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-230X-13-87

1 reference

Dimensions Publication ID

4 August 2017

0 references

1 reference

4 August 2017

1 reference